April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Clinical and Ocular Imaging Characteristics of Eyes With Visual Loss Over Time in Multiple Sclerosis
Author Affiliations & Notes
  • E. Bisker
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • S. Chang
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • A. Conger
    University of Texas Southwestern Medical Center, Dallas, Texas
  • G. Hiremath
    Johns Hopkins School of Medicine, Baltimore, Maryland
  • Y. Dai
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • G.-S. Ying
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • M. Maguire
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • E. Frohman
    University of Texas Southwestern Medical Center, Dallas, Texas
  • P. Calabresi
    Johns Hopkins School of Medicine, Baltimore, Maryland
  • L. Balcer
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  E. Bisker, None; S. Chang, None; A. Conger, None; G. Hiremath, None; Y. Dai, None; G.-S. Ying, None; M. Maguire, None; E. Frohman, None; P. Calabresi, None; L. Balcer, None.
  • Footnotes
    Support  National MS Society PP1115 (Dr. Balcer), National MS Society Translational Research Partnership TR 3760-A-3 (Drs. Calabresi and Balcer), National Eye Institute K24 EY 014136 (Dr. Balcer)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 927. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Bisker, S. Chang, A. Conger, G. Hiremath, Y. Dai, G.-S. Ying, M. Maguire, E. Frohman, P. Calabresi, L. Balcer; Clinical and Ocular Imaging Characteristics of Eyes With Visual Loss Over Time in Multiple Sclerosis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):927.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The purpose of this study was to determine the degree of retinal nerve fiber layer (RNFL) thinning by optical coherence tomography (OCT) that is associated with losses of low- and high-contrast acuity over time in a multiple sclerosis (MS) cohort. Visual dysfunction and axonal loss are common in MS. The emergence of OCT has allowed us to capture the unique structure-function correlations provided by the anterior visual pathway in MS.

Methods: : Patients with MS underwent OCT-3 imaging at baseline and at 6-month intervals during a mean follow-up period of 1.5 years (range 0.5-3.7) at three academic centers. RNFL thickness was measured for 360º around the optic disc. Visual function testing was performed using low-contrast (2.5 and 1.25% levels) and ETDRS acuity charts. Eyes with comorbid ocular conditions or acute ON within 3 months prior to testing were excluded.

Results: : Among 1,148 patients (2,296 eyes, age 44±11 years) who underwent baseline assessments, 365 (725 eyes) have participated in longitudinal follow-up. Worsening of low-contrast acuity was noted in 237 eyes of 123 patients (33% of MS eyes). Approximately 1/3 of eyes with visual loss had a past history of ON. Two-line (10-letter) losses of low-contrast acuity were associated, on average, with 1.6 µm decrements in RNFL thickness over time at 2.5% contrast (p=0.009, GEE models, accounting for age and within-patient, inter-eye correlations), and 3.7 µm reductions at 1.25% contrast (p=0.02). Patients with worsening vision were only slightly older (age 45 vs. 43 years), and had slightly greater disease duration (12 vs. 11 years).

Conclusions: : Visual loss occurs in a substantial proportion of MS eyes, and may be present even in the absence of a history of ON. Reductions in low-contrast acuity are associated with RNFL thinning over time, suggesting that axonal loss may be a significant contributor to visual dysfunction in MS.

Keywords: nerve fiber layer • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • visual impairment: neuro-ophthalmological disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×